Our non-contact, non-invasive biomarker measurement system, “FLD-A1c®,” has been implemented in an area accessible to researchers, including professors from the University of Tokyo, on one of its major campuses. It is specified that this is part of a collaborative project between our company and the University of Tokyo.
We will continue to advance joint projects with other leading academic institutions in Japan.